|
|
|
|
|
|
|
|
|
|
|
Victor
Wells
VP Finance & CFO |
|
|
|
Thank you, Mark.
Good morning ladies and gentlemen.
For the period
from July 18, 2001 to December 31, 2001, Chemtrade reported EBITDA of $13.7
million and distributable cash of $11.2 million. |
|
|
|
 |
|
|
|
|
|
|
In the IPO marketing
materials, we indicated expected annual EBITDA of $25.6 million and distributable
cash of $19.2 million, or about 37 cents per unit per quarter. When those
estimates are pro-rated for the five and a half months from July 18 to December
31, 2001, the result is EBITDA of $11.6 million and distributable cash of
$8.7 million. Comparing our actual results to these benchmark numbers for
the period, Chemtrade's performance was considerably ahead of the IPO expectations. |
|
|
|
These
results reflected strong performances from both our North American business
and from BCT Chemtrade. |
|
|
|
|
|
|
|
|
The North American
business was in line with our expectations for the period despite an unexpected
interruption in August to operations at our Timmins liquid sulphur dioxide
plant due to a problem at the Falconbridge Kidd Creek smelter.
Although there
were signs that the economic slowdown was affecting some industries -
such as a dramatic decrease in inventories by some end-use customers -
the nature of our contracts and the diversity of our customer base which
you saw in Mark's presentation, enabled us to avoid any serious fluctuations
in cash flow.
|
|
|
|
 |
|
|
|
|
BCT
Chemtrade also posted excellent results last year. BCT has a very solid customer
base which provides a strong, steady volume of product. When there is additional
spot supply, as there was in the fourth quarter of 2001, BCT is able to generate
increased earnings, and this contributed to our strong performance last year. |
|
|
|
 |
|
|
|
|
|
|
The
solid performance in 2001 has continued into 2002 and the first quarter was
still comfortably ahead of our IPO estimates. As you can see from this chart,
cash available for distribution was approximately $6.3 million which was generated
from EBITDA of $7.2 million. |
|
|
|
 |
|
|
|
|
|
|
The North American
business and BCT both performed well in the first three months of 2002. North
America benefited from the new agreement with Irving Oil and from a seasonal
increase in the availability of low cost sulphuric acid from a regeneration
facility that has extra volume in the winter months.
BCT Chemtrade's
business, like all of Chemtrade's, is very much supply driven. Due to the
tight market in the first quarter of 2002, the opportunities for spot volumes
on
|
|
|
the supply side
were not available, as they were in the fourth quarter of 2001. In spite of
this lack of spot product, BCT's first quarter results were in line with our
expectations.
Demand for our
products from end-use customers remained firm and there is evidence that industries
that had run down inventories late last year are now restocking in anticipation
of an improved economy later in the year.
These very satisfactory
results have led to returns for our unitholders that have exceeded our initial
expectations. |
|
|
|
 |
 |
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |